Vantourout P, Eum J, Conde Poole M, Hayday T, Laing A, Hussain K
Sci Adv. 2023; 9(49):eadj6174.
PMID: 38055824
PMC: 10699787.
DOI: 10.1126/sciadv.adj6174.
Hughes A, Kirkland M, Du W, Rasooly R, Hernlem B, Tam C
Toxins (Basel). 2023; 15(6).
PMID: 37368700
PMC: 10301076.
DOI: 10.3390/toxins15060400.
Nasiri G, Azarpira N, Alizadeh A, Goshtasbi S, Tayebi L
Stem Cell Res Ther. 2020; 11(1):421.
PMID: 32993791
PMC: 7523352.
DOI: 10.1186/s13287-020-01929-8.
Truant S, De Marzi M, Sarratea M, Antonoglou M, Meo A, Iannantuono Lopez L
Front Immunol. 2020; 10:3008.
PMID: 32010128
PMC: 6974467.
DOI: 10.3389/fimmu.2019.03008.
Rasooly R, Do P, He X, Hernlem B
Toxins (Basel). 2019; 11(7).
PMID: 31295829
PMC: 6669470.
DOI: 10.3390/toxins11070399.
Staphylococcus aureus toxin antibodies: Good companions of antibiotics and vaccines.
Bagnoli F
Virulence. 2017; 8(7):1037-1042.
PMID: 28267417
PMC: 5711431.
DOI: 10.1080/21505594.2017.1295205.
Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
Karau M, Tilahun M, Krogman A, Osborne B, Goldsby R, David C
Virulence. 2016; 8(7):1148-1159.
PMID: 27925510
PMC: 5711449.
DOI: 10.1080/21505594.2016.1267894.
Construction and characterization of VL-VH tail-parallel genetically engineered antibodies against staphylococcal enterotoxins.
He X, Zhang L, Liu P, Liu L, Deng H, Huang J
Immunol Res. 2015; 61(3):281-93.
PMID: 25608796
DOI: 10.1007/s12026-015-8623-7.
Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression.
Kulhankova K, King J, Salgado-Pabon W
Immunol Res. 2014; 59(1-3):182-7.
PMID: 24816557
DOI: 10.1007/s12026-014-8538-8.
Gram-positive and gram-negative bacterial toxins in sepsis: a brief review.
Ramachandran G
Virulence. 2013; 5(1):213-8.
PMID: 24193365
PMC: 3916377.
DOI: 10.4161/viru.27024.
Assessment of the functional regions of the superantigen staphylococcal enterotoxin B.
Zhang L, Rogers T
Toxins (Basel). 2013; 5(10):1859-71.
PMID: 24152989
PMC: 3813916.
DOI: 10.3390/toxins5101859.
Pathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease.
Katano H, Sato S, Sekizuka T, Kinumaki A, Fukumoto H, Sato Y
Int J Clin Exp Pathol. 2012; 5(8):814-23.
PMID: 23071864
PMC: 3466979.
Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88.
Kissner T, Ruthel G, Alam S, Mann E, Ajami D, Rebek M
PLoS One. 2012; 7(7):e40773.
PMID: 22848400
PMC: 3407147.
DOI: 10.1371/journal.pone.0040773.
Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.
Tilahun M, Kwan A, Natarajan K, Quinn M, Tilahun A, Xie C
PLoS One. 2011; 6(11):e27203.
PMID: 22102880
PMC: 3216929.
DOI: 10.1371/journal.pone.0027203.
Multiple roles of Staphylococcus aureus enterotoxins: pathogenicity, superantigenic activity, and correlation to antibiotic resistance.
Ortega E, Abriouel H, Lucas R, Galvez A
Toxins (Basel). 2011; 2(8):2117-31.
PMID: 22069676
PMC: 3153285.
DOI: 10.3390/toxins2082117.
Induction of contact-dependent CD8(+) regulatory T cells through stimulation with staphylococcal and streptococcal superantigens.
Taylor A, L A Cross E, Llewelyn M
Immunology. 2011; 135(2):158-67.
PMID: 22043981
PMC: 3277718.
DOI: 10.1111/j.1365-2567.2011.03529.x.
Solid tumor-targeted infiltrating cytotoxic T lymphocytes retained by a superantigen fusion protein.
Sun J, Zhao L, Teng L, Lin F, Zhang H, Li Z
PLoS One. 2011; 6(2):e16642.
PMID: 21311755
PMC: 3032773.
DOI: 10.1371/journal.pone.0016642.
Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules.
Kissner T, Ruthel G, Alam S, Ulrich R, Fernandez S, Saikh K
PLoS One. 2011; 6(1):e15985.
PMID: 21283748
PMC: 3024394.
DOI: 10.1371/journal.pone.0015985.
Staphylococcal enterotoxin A induction of pro-inflammatory cytokines and lethality in mice is primarily dependent on MyD88.
Kissner T, Cisney E, Ulrich R, Fernandez S, Saikh K
Immunology. 2010; 130(4):516-26.
PMID: 20465563
PMC: 2913262.
DOI: 10.1111/j.1365-2567.2010.03249.x.
Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies.
Tilahun M, Rajagopalan G, Shah-Mahoney N, Lawlor R, Tilahun A, Xie C
Infect Immun. 2010; 78(6):2801-11.
PMID: 20308304
PMC: 2876561.
DOI: 10.1128/IAI.01121-09.